Articles from 2021
Ecologists are teaming up with genomics and CRISPR-Cas experts to create the first genomic portrait of cyanobacteria that play a key role in northern ecosystems.
Bacteria found in fossilized human feces hundreds of years old are intriguing researchers who wonder if they could open up new therapeutic avenues for treating chronic diseases such as diabetes and obesity.
Articles from 2020
Blueberry polyphenols are believed to reduce weight gain through the intestinal microbiota.
The endocannabinoidome is a complex signaling pathway consisting of several G protein-coupled receptors, metabolic enzymes and more than 20 lipid mediators. Recent research links this pathway to intestinal health. With the discovery of endocannabinoid receptors in the gut, mechanisms underlying crosstalk between such receptors and the gut microbiota are being investigated. Scientists have speculated that a dysregulated endocannabinoid system may lead to inflammatory bowel disease and colon cancer. […]
Articles from 2019
Weight gain and diet have long been known to shuffle the population of gut microbes. More recently, studies have also connected weight gain and diet to changes in the intestinal endocannabinoid system (eCB), a complex network of metabolites and receptors that help regulate appetite and metabolism, among other chores. […]
When analyzing genomic data, I usually try to push further and get the most of each approaches. Here is the story behind some of the methods we used in our recent work investigating the resistance genes found in gut microbiomes, particularly in the lower abundance bacteria.